Skip to main content

Table 1 Characteristics of the patients and tumors

From: Clustering subtypes of breast cancer by combining immunohistochemistry profiles and metabolism characteristics measured using FDG PET/CT

Characteristics Hormonal
(n = 182)
HER2
(n = 24)
Dual Positive
(n = 47)
Triple Negative
(n = 36)
P
Age (y) 54.8 ± 11.0 55.6 ± 10.2 53.5 ± 9.4 55.5 ± 12.1 0.813
Histology      
IDC 150 20 44 28 0.067
ILC 14 1 1 0  
Others 8 3 2 8  
T stage      
T1 121 17 24 26 0.572
T2 54 7 21 10  
T3 6 0 2 0  
T4 1 0 0 0  
N stage      0.165
N0 109 18 31 31  
N1 56 6 11 5  
N2 13 0 4 0  
N3 4 0 1 0  
Nuclear grade      < 0.001*
1 77 0 5 2  
2 85 7 19 11  
3 20 17 23 23  
Stage      0.451
IA 84 15 17 23  
IB 8 0 1 1  
IIA 51 5 20 10  
IIB 20 4 4 2  
IIIA 14 0 4 0  
IIIB 1 0 0 0  
IIIC 4 0 1 0  
Operation      0.256
BCS 119 13 25 28  
MRM 52 9 19 8  
SSM 11 2 3 0  
  1. BCS breast conserving surgery, IDC invasive ductal carcinoma, ILC invasive lobular carcinoma, MRM modified radical mastectomy, SSM skin-sparing mastectomy; *P < 0.05